DigestRedComo funciona
Red
/
Empresas
Sa
No verificado

Sandoz Group

Sobre qué escribimos

Anuncios brevesFarmacéuticaGestión empresarial/Administración de EmpresasPolítica InternacionalPublicidad/Marketing/Medios de comunicación/Comunicación

21 Comunicados de prensa

Ver todos los comunicados de prensa
11/08/2025
Farmacéutica
Anuncios breves
Política Internacional
Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
Fuente
Sandoz Group
Editor
GLOBENEWSWIRE
1.00
0
06/08/2025
Farmacéutica
Anuncios breves
Política Internacional
Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
Fuente
Sandoz Group
Editor
GLOBENEWSWIRE
1.00
0
29/07/2025
Farmacéutica
Publicidad/Marketing/Medios de comunicación/Comunicación
Anuncios breves
Política Internacional
Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
Fuente
Sandoz Group
Editor
GLOBENEWSWIRE
1.00
0
01/07/2025
Farmacéutica
Anuncios breves
Política Internacional
Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
Fuente
Sandoz Group
Editor
GLOBENEWSWIRE
1.00
0
01/06/2025
Farmacéutica
Anuncios breves
Política Internacional
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
Fuente
Sandoz Group
Editor
GLOBENEWSWIRE
1.00
0
21/05/2025
Farmacéutica
Anuncios breves
Política Internacional
Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
Fuente
Sandoz Group
Editor
GLOBENEWSWIRE
1.00
0
29/04/2025
Farmacéutica
Anuncios breves
Política Internacional
Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
Fuente
Sandoz Group
Editor
GLOBENEWSWIRE
1.00
0
29/04/2025
Farmacéutica
Anuncios breves
Política Internacional
Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
Fuente
Sandoz Group
Editor
GLOBENEWSWIRE
1.00
0
15/04/2025
Farmacéutica
Anuncios breves
Política Internacional
Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
Fuente
Sandoz Group
Editor
GLOBENEWSWIRE
1.00
0
14/04/2025
Farmacéutica
Anuncios breves
Política Internacional
[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
Fuente
Sandoz Group
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0